This document provides information about a 53-year-old female patient diagnosed with gastric adenocarcinoma. It includes sections on the patient's demographic profile, present health history, past health history, family history, social history, developmental history, and activities of daily living. The patient underwent total gastrectomy and chemotherapy and experiences side effects from treatment including nausea, vomiting, weakness and diarrhea. She is in the 11th cycle of chemotherapy and was admitted for her current treatment.
This document provides information about a 53-year-old female patient diagnosed with gastric adenocarcinoma. It includes sections on the patient's demographic profile, present health history, past health history, family history, social history, developmental history, and activities of daily living. The patient underwent total gastrectomy and chemotherapy and experiences side effects from treatment including nausea, vomiting, weakness and diarrhea. She is in the 11th cycle of chemotherapy and was admitted for her current treatment.
This document provides information about a 53-year-old female patient diagnosed with gastric adenocarcinoma. It includes sections on the patient's demographic profile, present health history, past health history, family history, social history, developmental history, and activities of daily living. The patient underwent total gastrectomy and chemotherapy and experiences side effects from treatment including nausea, vomiting, weakness and diarrhea. She is in the 11th cycle of chemotherapy and was admitted for her current treatment.
This document provides information about a 53-year-old female patient diagnosed with gastric adenocarcinoma. It includes sections on the patient's demographic profile, present health history, past health history, family history, social history, developmental history, and activities of daily living. The patient underwent total gastrectomy and chemotherapy and experiences side effects from treatment including nausea, vomiting, weakness and diarrhea. She is in the 11th cycle of chemotherapy and was admitted for her current treatment.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 5
University of the East Ramon Magsaysay
Memorial Medical Center Inc.
#64 Aurora Boulevard, Barangay Dona Imelda, Quezon City, Philippines 1113
In partial fulfillment of Summer Enhancement 2014
NURSING CARE PROCESS
Submitted to: Maam Janelle Castro
Submitted by: Susmiran, Michelle Anne C. N3-A3
INTRODUCTION
This is a case of a 53 year old female that was diagnosed with Gastric Adenocarcinoma. Gastric cancer is the one of the most common cancer in the world after lung and is a major cause of mortality and morbidity. Through a marked reduction has been observed in the incidence of gastric carcinoma in in North America and Western Europe in the last 50 years, 5-year survival rates are rates are less than 20%, as most patients present late and are unsuitable for curative, radical surgery.
Gastric cancer can develop in any part of the stomach and may spread throughout the stomach and to other organs: particularly the esophagus, lungs, lymph nodes, and the liver. Stomach cancer causes about 800,000 deaths worldwide. Comes from several Hystological types of Gastric Cancer of which adenocarcinoma is by far the most frequent. Sarcomas and Lymphomas can also occur.
EPIDEMIOLOGY
Gastric cancer is one of the most common cancers worldwide. Approximately 22,220 patients are diagnosed annually in the United States, of whom 10,990 are expected to die. Global, country-specific incidence rates are available in the World Health Organization GLOBOCAN database. Gastric cancer used to be the leading cause of cancer deaths in the world until the 1980s when it was overtaken by lung cancer. The worldwide incidence of gastric cancer has declined rapidly over the recent few decades. Part of the decline may be due to the recognition of certain risk factors such as H. pylori and other dietary and environmental risks. However, the decline clearly began before the discovery of H. pylori. The decline first took place in countries with low gastric cancer incidence such as the United States (beginning in the 1930s), while the decline in countries with high incidence like Japan was slower. In the United Kingdom, there was a consistent decline in incidence of gastric cancer, with a reduction in RR from 1.14 in 1971 to 1975 to 0.84 in 1996 to 2009 in men, and 1.18 in 1971 to 1975 to 0.81 in 1996 to 2009 in women. In China, the decline was less dramatic than other countries; despite an overall decrease in gastric cancer incidence, an increase has been observed in the oldest and the youngest group, and a less remarkable decline has been observed among women than in men. Of note is that the age of onset of developing gastric cancer in Chinese population is younger than that in the West. In the United States, risk factors for noncardia gastric cancer include male gender, non-white race, and older age. Between 1977 and 2009, the incidence rate for noncardia gastric cancer in the United States declined among all race and age groups except for whites aged 29 to 39 years for whom it increased. The rise in incidence of noncardia gastric cancer among those at 25 to 39 years is noteworthy since this may signal the introduction of new environmental factors.
Demographic Profile
Patients name: L.F. Address: 1571 Morales St. Lolomboy, Bucaue Bulacan. Age/Gender: 53 years old/Female Nationality: Filipino Religion: Roman Catholic Marital Status: Married Educational Attainment: Elementary graduate Occupation: House wife
Chief Complaint: 11 th cycle of chemotherapy Source of liability: Patient herself of good reliability Date of admission: May 03, 2014 Admitting Diagnosis: Gastric Adenocarcinoma, Poorly Differentiated Stage III-B Attending Physician: Dr. Isauro Guiang, MD.
PRESENT HEALTH HISTORY 12 months PTA, patients symptoms of epigastric pain worsened noting a 7/10 and are now associated with nausea and vomiting, and vomitus is described as the food eaten prior to the episode. Patient then sought consult after 2 week and had endoscopy with shaved a mass in the intestine. She has been known to have Gastric Carcinoma, poorly differentiated stage III-B. Patient was then advised to have surgery and then after that 2 weeks, she was admitted to the UERM hospital and underwent total gastrectomy roux-en-y esophagojejunostomy. After the operation, patient and significant other noted weight loss from 55-35kg but no other complications were revealed.
8 months PTA, patient started her chemotherapy treatment and at present is on the 11 th cycle of the chemotherapy. Patient noted to have nausea, vomiting, weakness, diarrhea, and polyuria after treatment but these symptoms reveal spontaneously every time she is about to start her succeeding cycles. On the day of admission, the patient was admitted to the UERM Hospital for the 11 th cycle chemotherapy (5FU).
PAST HEALTH HISTORY
Patient L.F. has vaccinated completely during her childhood times. She had experienced chicken pox as well as measles with unrecalled date. She had underwent some surgeries such as Hemmorrhoidectomy (2006); Cholecystectomy (2012); Total Gastrectomy and Roux-en-y Esophagojejunostomy (2013) in UERM hospital.
Gastric Adenocarcinoma Diabetes Mellitus Type 2 Lung Cancer Lung Cancer
FAMILY HISTORY
Male Female Patient Deceased
SOCIAL HISTORY Patient L.F. is a non-smoker individual and a non-beverage drinker. She is an elementary graduate who is a plain housewife who has been living together with her husband but her son lives with his own family. She is financially supported by her husband and son. The patients family supports her all throughout the process of this chemotherapy. Their house is made of semi-concrete with 3 occupants as the patient stated.
DEVELOPMENTAL HISTORY Care: Generativity vs. Stagnation (Middle adulthood, 25-64, or 40-64 years) - Aging speeds up during this time, and it is characterized by further vision problems, hearing loss, and the end of reproductive capability for women, known as menopause. - During middle age the primary developmental task is one of contributing to society and helping to guide future generations. When a person makes a contribution during this period, perhaps by raising a family or working toward the betterment of society, a sense of gene rativity- a sense of productivity and accomplishment- results. In contrast, a person who is self-centered and unable or unwilling to help society move forward develops a feeling of stagnation- a dissatisfaction with the relative lack of productivity.
Unrecalled Unrecalled - Central tasks of middle adulthood - Help growing and grown children to be responsible adults. - Relinquish central role in lives of grown children. - Create a comfortable home. - Adjust to physical changes of middle age. - ACTIVITIES OF DAILY LIVING
Patient L.F. wakes up early at 4:00 in the morning. Do her all house hold chores accompanied by her husband sometimes. Cleaning the house is her priority in every morning upon waking up in the morning. Sometimes she waters the plant as well. After all the morning chores, she prepares their lunch and does before and after meal chores but sometimes due to weakness, she is unable to accomplish them. She usually has her afternoon nap but in irregular sleep pattern and then upon wakeing up, shell watch her favorite TV show on television until dinner time comes. 9:00 pm is her regular time in sleeping.